Covid-19 and Disparities in Nutrition and ObesityMatthew J. Belanger, Christos S. Mantzoros, Μaria Dalamaga et al.|New England Journal of Medicine|2020Cited by 235
Commentary: COVID-19 in patients with diabetesMichael A. Hill, James R. Sowers, Christos S. Mantzoros|Metabolism|2020Cited by 184
Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: Trials, opportunities, and challengesMichail Kokkorakis, Christos S. Mantzoros, Chrysoula Boutari et al.|Metabolism|2024Cited by 138